MAPT and Alzheimer disease: Here, we identified prominent neuronal PAD4 expression along with marked depositions of retinal and cortical citrullinated arginine (R)-209 tau (CitR209-tau) and AT8+p-tau (S202/T205) in MCI and AD patients compared to NC controls (Fig. 7b–d).